Drug-like Properties and ADME of Xanthone Derivatives: The Antechamber of Clinical Trials

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|23|32|3654-3686

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.23, Iss.32, 2016-10, pp. : 3654-3686

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Improvement of drug-like properties of peptides: the somatostatin paradigm

By Ovadia Oded   Greenberg Sarit   Laufer Burkhardt   Gilon Chaim   Hoffman Amnon   Kessler Horst  

Expert Opinion on Drug Discovery, Vol. 5, Iss. 7, 2010-07 ,pp. : 655-671

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic Properties and In Silico ADME Modeling in Drug Discovery

By  

Medicinal Chemistry, Vol. 9, Iss. 2, 2013-03 ,pp. : 163-176

Bentham Science Publishers

Access to resources Recommend Favorite

Selecting Good ‘Drug-Like’ Properties to Optimize Small Molecule Blood-Brain Barrier Penetration

By  

Current Medicinal Chemistry, Vol. 23, Iss. 14, 2016-04 ,pp. : 1392-1407

Bentham Science Publishers

Access to resources Recommend Favorite

Prediction of the Corneal Permeability of Drug-Like Compounds

By Kidron Heidi   Vellonen Kati-Sisko   Amo Eva   Tissari Anita   Urtti Arto  

Pharmaceutical Research, Vol. 27, Iss. 7, 2010-07 ,pp. : 1398-1407

Springer Publishing Company

Access to resources Recommend Favorite

Drug-Like Property Concepts in Pharmaceutical Design

By  

Current Pharmaceutical Design, Vol. 15, Iss. 19, 2009-07 ,pp. : 2184-2194

Bentham Science Publishers

Access to resources Recommend Favorite